Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 68382-441

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68382-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

73ee6f58 3c80 4bb1 8757 1ecddb8868fe 01

Chemical structure diagram of esomeprazole magnesium, a pharmaceutical compound involving two esomeprazole molecules coordinated with magnesium and associated with two water molecules (hydration).*

FDA Label Image

73ee6f58 3c80 4bb1 8757 1ecddb8868fe 02

A line graph showing the percentage of subjects maintaining a condition over six months, comparing esomeprazole magnesium at doses of 40 mg, 20 mg, 10 mg, and a placebo. The vertical axis represents percent maintained, and the horizontal axis represents time in months. Higher doses show greater maintenance percentages over time.*

FDA Label Image

73ee6f58 3c80 4bb1 8757 1ecddb8868fe 03

A line chart depicting the percent maintained over a six-month period for esomeprazole magnesium at 40 mg, 20 mg, and 10 mg dosages compared to placebo. The y-axis represents percent maintained from 0 to 100%, and the x-axis represents months from 0 to 6. The chart shows higher maintenance percentages for the 40 mg and 20 mg dosages compared to 10 mg and placebo groups, with respective patient counts noted in the legend.*

FDA Label Image

73ee6f58 3c80 4bb1 8757 1ecddb8868fe 04

A line graph depicting the percent of patients symptom-free over 28 diary days for esomeprazole magnesium 20 mg, 40 mg, and placebo groups. The y-axis shows percent symptom-free from 0 to 100, and the x-axis shows diary days from 0 to 28. Both esomeprazole doses show higher symptom-free percentages compared to placebo throughout the period.*

FDA Label Image

73ee6f58 3c80 4bb1 8757 1ecddb8868fe 05

A line graph showing the percentage of patients symptom-free over a 28-day diary period for esomeprazole magnesium 20 mg and 40 mg doses compared to placebo. The y-axis represents the percent of symptom-free patients, and the x-axis shows diary days from 0 to 28.*

FDA Label Image

73ee6f58 3c80 4bb1 8757 1ecddb8868fe 06

Label for esomeprazole magnesium delayed-release capsules, USP, 20 mg strength. The package contains 30 capsules and is labeled for prescription use only (Rx only). The label includes storage instructions, child resistance information, and a reminder to dispense the Medication Guide separately. The product is from Zydus Pharmaceuticals USA Inc., with manufacturing in India and distribution in New Jersey.*

FDA Label Image

73ee6f58 3c80 4bb1 8757 1ecddb8868fe 07

Label for Esomeprazole Magnesium Delayed-Release Capsules, USP, 40 mg strength, from Zydus Pharmaceuticals USA Inc. The package contains 30 capsules for oral use and is prescription only. The label includes directions for pharmacists to dispense the Medication Guide separately. It also notes storage instructions, child-resistant packaging, and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.